ERF13 antibodies are polyclonal or monoclonal reagents that bind specifically to the ERF13 protein, enabling its detection and functional analysis. These antibodies are essential for:
Western blotting: Quantifying ERF13 protein levels under varying conditions (e.g., stress, pathogen infection) .
Co-immunoprecipitation (Co-IP): Identifying ERF13-interacting proteins, such as ubiquitin ligases MAC3A and MAC3B .
Immunolocalization: Determining ERF13 subcellular localization (e.g., nuclear localization confirmed via BiFC assays) .
Overexpression effects: ERF13 overexpression in Arabidopsis increases susceptibility to Pseudomonas syringae by disrupting hormone crosstalk (SA, JA, ET, ABA) and promoting chlorosis .
Pathogenesis-related gene activation: ERF13 stimulates PDF1.2a, a JA/ET-responsive gene, even while suppressing pathogen resistance .
Ubiquitination and proteasomal degradation:
ERF13 is ubiquitinated by MAC3A/MAC3B E3 ligases, facilitated by auxin-induced phosphorylation via MPK14 .
Phosphorylation at Thr66, Ser67, and Thr124 enhances ERF13’s affinity for MAC3A/MAC3B, leading to degradation (Fig. 1) .
Key experimental data:
| ERF13 Variant | Degradation Rate (WT vs. mac3a mac3b mutant) | Interaction Strength with MAC3A/MAC3B |
|---|---|---|
| Wild-type | High in WT, low in mutant | Moderate |
| ERF13 AAA | Stable in both genotypes | Weak |
| ERF13 DDD | Rapid in WT, stable in mutant | Strong |
Lateral root emergence: ERF13 inhibits lateral root formation by suppressing KCS gene expression. Degradation via MAC3A/MAC3B restores root development .
Constructs: ERF13-MYC, MAC3A-GFP, and ubiquitin-MYC co-expressed in protoplasts .
Antibodies:
Key result: Auxin treatment strengthens ERF13-MAC3A/MAC3B interaction, confirmed via Co-IP (Fig. 5C–D) .
Phosphomimetic (DDD) vs. non-phosphorylatable (AAA) mutants:
ERF13 is an Arabidopsis transcription factor belonging to the B-3 ERF family subgroup (reclassified to group IX in Nakano et al., 2006). It plays a critical role in mediating plant responses to both biotic and abiotic stresses. Research has demonstrated that ERF13 acts as a negative regulator of defense against Pseudomonas syringae, with overexpression inducing susceptibility to bacterial pathogens . Additionally, ERF13 inhibits lateral root emergence by suppressing the expression of 3-KETOACYL-COA SYNTHASEs (KCSs) . Its position at the junction of multiple hormone signaling pathways (SA, JA, ET, and ABA) makes it a crucial component in understanding how plants coordinate defense responses and development .
While the search results don't specifically mention antibody types for ERF13, typical antibodies used in plant research include:
Polyclonal antibodies: Used for general detection of ERF13 protein
Monoclonal antibodies: Provide higher specificity for particular epitopes
Phospho-specific antibodies: Especially valuable for detecting phosphorylated ERF13 at S168, which increases during early effector-triggered immunity
For ERF13 research, antibodies that can distinguish between phosphorylated and non-phosphorylated forms are particularly valuable, as phosphorylation at S168 has been shown to increase during RPM1-mediated effector-triggered immunity .
To verify ERF13 antibody specificity:
Run Western blots comparing wild-type plants with erf13 mutants or knock-down lines
Include positive controls using tissue from ERF13 overexpression lines (e.g., Pro35S:GFP-ERF13)
Perform pre-absorption tests with recombinant ERF13 protein
Test cross-reactivity with closely related ERF family members, particularly those with high sequence homology
Validate with orthogonal methods such as mass spectrometry identification of immunoprecipitated proteins
This validation is critical as ERF13 shares high sequence homology with other defense-related ERFs, which could lead to cross-reactivity .
ERF13 undergoes phosphorylation at S168 during early effector-triggered immunity . To study these dynamics:
Use phospho-specific antibodies that recognize ERF13 phosphorylated at S168
Implement time-course experiments following pathogen challenge or PAMP treatment
Compare phosphorylation patterns between compatible and incompatible plant-pathogen interactions
Use phosphatase treatments as controls to confirm specificity of phospho-antibodies
Combine with kinase inhibitor treatments to identify responsible kinases
Proteome profiling has shown that S168-phosphorylated ERF13 increases concurrent with early effector-triggered immunity mediated by the R protein RPM1 . This approach can reveal how post-translational modifications regulate ERF13 function during immune responses.
Research has shown that ERF13 is degraded through a ubiquitin-proteasome pathway involving the E3 ligases MAC3A and MAC3B . To study this process:
Perform time-course experiments with auxin treatment and use antibodies to track ERF13 protein levels
Compare degradation kinetics between wild-type plants and mac3a mac3b mutants
Implement proteasome inhibitors (e.g., MG132) to prevent degradation
Use co-immunoprecipitation with anti-FLAG antibodies to detect ubiquitinated forms of ERF13
Design pulse-chase experiments to measure half-life of ERF13 protein in different genetic backgrounds
The following table summarizes observed degradation patterns of ERF13 variants:
| ERF13 Variant | Interaction with MAC3A/B | Degradation Rate in WT | Stability in mac3a mac3b | NAA Response |
|---|---|---|---|---|
| ERF13 DDD (phospho-mimic) | Strong | Rapid degradation | Highly stable | Insensitive |
| ERF13 AAA (non-phosphorylatable) | Weak | Relatively stable | Highly stable | Insensitive |
| Wild-type ERF13 | Auxin-enhanced | Normal degradation | Stable | Sensitive |
These approaches reveal that auxin promotes ERF13 degradation through phosphorylation-dependent recruitment of MAC3A and MAC3B .
ChIP with ERF13 antibodies can reveal direct transcriptional targets:
Fix plant tissue with formaldehyde to crosslink DNA-protein complexes
Shear chromatin to appropriate fragment sizes (typically 200-500 bp)
Immunoprecipitate with ERF13-specific antibodies
Purify and analyze bound DNA by qPCR or sequencing
Compare binding profiles during normal conditions versus pathogen challenge or hormone treatments
Potential targets to examine include JA/ET-inducible genes such as PDF1.2a, which has been shown to be stimulated by ERF13 overexpression . Additionally, KCS genes, which are suppressed by ERF13 during lateral root development, would be valuable targets to confirm direct binding .
When performing immunoprecipitation (IP) with ERF13 antibodies:
Input control: Reserve a portion of pre-cleared lysate before IP
Negative control: Perform parallel IP with pre-immune serum or IgG from the same species
Genetic control: Include erf13 mutant or knockdown lines
Specificity control: Pre-absorb antibody with recombinant ERF13 protein
Technical control: Use tagged versions (e.g., ERF13-MYC) and perform parallel IP with tag-specific antibodies
IP experiments have successfully identified ERF13 interacting partners, including the E3 ubiquitin ligases MAC3A and MAC3B, using Pro35S:ERF13-MYC seedlings coupled with liquid chromatography–tandem mass spectrometry (LC-MS/MS) .
To study ERF13 phosphorylation dynamics:
Design a time-course experiment with samples collected at multiple timepoints post-infection
Include both virulent and avirulent pathogen strains (e.g., Pst DC3000 with and without AvrRpm1)
Use phospho-specific antibodies targeting S168 of ERF13
Implement controls with kinase inhibitors to block phosphorylation
Compare phosphorylation patterns between wild-type plants and defense signaling mutants
Research has demonstrated that early AvrRpm1-triggered ETI signaling causes an increase in ERF13 phosphorylation at S168 . This experimental design allows for temporal resolution of post-translational modifications during plant immune responses.
To quantify ERF13 protein levels accurately:
Western blot analysis with serial dilutions of recombinant ERF13 as standards
Quantitative ELISA using purified ERF13 protein to generate standard curves
Mass spectrometry-based quantification using labeled internal standards
Fluorescence-based detection systems with GFP-tagged ERF13 constructs
Compare protein levels with transcript levels using both Western blot and RT-qPCR
When studying protein degradation, it's crucial to include proteasome inhibitors like MG132 to prevent degradation during sample preparation . This approach has been successfully used to demonstrate that auxin promotes the degradation of ERF13 through the MPK14-MAC3A and MAC3B signaling module.
When facing low detection sensitivity:
Implement signal amplification methods such as enhanced chemiluminescence (ECL) or tyramide signal amplification
Concentrate proteins using immunoprecipitation prior to Western blotting
Use tagged overexpression lines (e.g., Pro35S:ERF13-MYC or Pro35S:GFP-ERF13) for increased abundance
Optimize extraction buffers to improve protein solubility and reduce proteolytic degradation
Consider using more sensitive detection methods like proximity ligation assay (PLA) for in situ detection
Research groups have successfully used GFP-tagged ERF13 to track protein levels during lateral root development, demonstrating that as MAC3A gradually accumulates in the lateral root primordium, ERF13 levels decrease .
To minimize cross-reactivity:
Generate antibodies against unique regions of ERF13 rather than conserved domains
Perform extensive pre-absorption tests with recombinant proteins of related ERFs
Validate specificity using erf13 mutants and other erf mutant lines
Consider using epitope-tagged ERF13 constructs in transgenic plants
Implement sequential immunoprecipitation to improve specificity
Cross-reactivity is a particular concern as AtERF13 shares a high degree of homology with Pti4 and other defense-related ERFs . Careful antibody design and validation are essential to ensure specificity.
To distinguish between different post-translationally modified forms:
Use phospho-specific antibodies that recognize phosphorylated S168
Employ 2D gel electrophoresis to separate different phosphorylated species
Implement Phos-tag SDS-PAGE to enhance mobility shifts of phosphorylated proteins
Apply mass spectrometry to identify and quantify specific modifications
Compare protein mobility with phospho-mimic (ERF13 DDD) and non-phosphorylatable (ERF13 AAA) variants
Research has shown that phosphorylation enhances the interaction between ERF13 and the E3 ligases MAC3A and MAC3B, leading to more rapid degradation . These techniques help elucidate how post-translational modifications regulate ERF13 stability and function.
ERF13 functions at the intersection of multiple hormone signaling pathways . To study this crosstalk:
Apply different hormone treatments (SA, JA, ET, ABA) and track ERF13 protein levels and modifications
Use ERF13 antibodies in co-IP experiments to identify hormone-specific interacting partners
Perform ChIP-seq after hormone treatments to identify condition-specific DNA binding patterns
Compare ERF13 protein dynamics in hormone signaling mutants
Implement biosensor approaches with tagged ERF13 to visualize real-time responses to hormones
This approach can reveal how ERF13 negotiates the crosstalk between hormones that shapes and tailors plant defense responses, as it has been shown that ERF13 lies at a junction in the signaling pathways of SA, JA, ET, and ABA .
ERF13 antibodies can advance crop resistance research by:
Comparing ERF13 protein dynamics between resistant and susceptible crop varieties
Tracking ERF13 expression and modification patterns during pathogen infection in economically important crops
Screening for breeding lines with optimal ERF13 expression or modification patterns
Validating the conservation of ERF13-mediated defense mechanisms across different plant species
Developing diagnostic tools to assess plant immune status based on ERF13 modification patterns
As food security is directly related to plant health, understanding ERF13's role in immunity can help develop crops with enhanced disease resistance . The negative regulatory role of ERF13 in defense against P. syringae suggests that modulating its activity could improve crop protection strategies.